此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Comparing Different Amounts of Vitamin D Supplementation to Preschool Children Living in Northern and Southern Sweden (Dvisum)

2016年10月31日 更新者:Torbjörn Lind、Umeå University

Vitamin D has a range of biological effects of public health relevance. Vitamin D status is assessed on levels of its metabolite 25-hydroxyvitamin D [25(OH)D], where levels < 50 nmol/L indicate insufficiency. Despite studies indicating that the vitamin D intake among Swedish children are significantly below recommendations, little is known of their vitamin D status. The investigators have recently found inadequate vitamin D status in pre-school children living in northern Sweden, especially in dark-skinned children and during the winter months despite vitamin D intakes meeting the recommendations. Overall, 25% of the light skinned and 40% of the dark skinned children had S-25(OH) D <50 nmol/L (Öhlund I, unpublished data). The aim is to examine which amount of vitamin D is needed to maintain or increase S-25(OH)D to ≥50 nmol/L among 97.5% of the participants regardless of skin color or geographic location (northern or southern Sweden). Furthermore the investigators will examine if vitamin D status affects on health markers as bone density, blood pressure, serum lipids, fatty acids, inflammatory and immunological markers and mental wellbeing.

Children aged 5-8 years living either northern (Umeå) or southern Sweden (Malmö) will be recruited to this trial during November-December 2012. They will be randomized to a vitamin D supplement of either 10 or 25 g per day, or in Malmö also placebo to be used for three months. The randomization will be stratified according to skin color (light or dark) according to a method using visual inspection and interviews of parents/guardians. The investigators will use a 2×2×2 factorial design to investigate the effects of two different doses of vitamin D (10 µg and 25 µg) in children with dark and light skin color, living in northern (Umeå) and southern (Malmö), Sweden. In order to achieve a moderate difference between groups (effect size 0.25) 20 children per group are required (power> 87%, alpha = 0.05). With an estimated dropout of 10%, a total of 220 children will be included.

At baseline, the participants will undergo blood sampling for S-25(OH)D and other biomarkers, blood pressure and anthropometrical measurements, including bone densitometry and body composition using air displacement pletysmography, and the parents will answer a questionnaire on behavioral and emotional problems in the participating child using the Child Behavior Checklist. These measurements will be repeated at follow-up in February-March 2013.

研究概览

详细说明

Vitamin D has a range of biological effects of public health relevance (Prentice et al, 2008). Besides its well known role in mineralization of bone and teeth, vitamin D also play important roles in metabolic functions, the pathogenesis of certain diseases, e.g. type 1 diabetes, celiac disease, asthma and allergies, as well as in the prevention of cancer (Holick, 2008).

Vitamin D status is assessed on plasma or serum levels of its metabolite 25-hydroxyvitamin D [25(OH)D, calcidiol] as it reflects the sum of vitamin D converted in the skin through sunlight exposure and from dietary sources. Several reports advocate that levels <37 nmol/L denote severe vitamin D deficiency; levels <50 nmol/L insufficient; 50-75 nmol/L suboptimal levels and ≥75nmol/L optimal levels (Dawson-Hughes et al, 2005, Huh et al, 2008, Yetley, 2008). In children, most suggested cut-off values for adequate levels of 25(OH)D are based on the absence of rickets, increased measures of bone mineralization and maximal suppression of parathyroid hormone (PTH) levels (Greer, 2009).

The major source of vitamin D is dermal biosynthesis catalyzed by ultraviolet B sunlight (Cashman et al, 2011). However, during winter, northern Sweden has limited hours of daylight leading to reduced sun exposure. Consequently, the dietary source of vitamin D is of specific importance in this region (Brustad et al, 2007, Edvardsen et al, 2007). Fatty fish, eggs, vitamin D fortified milk and margarines are the main sources, mainly supplying the most active form D3. These are important basic foods which also contain common food allergens. Thus, children with food allergies to milk, fish, and egg can be at increased risk of vitamin D deficiency. Several dairy products are fortified with vitamin D, but in some products in the form of D2 which is not as bioactive as D3.

Skin color affects the capacity to form vitamin D3 as children with dark complexion need 5-10 times more sun exposure to generate the same amount of vitamin D3 compared to fair-skinned children, and therefore are at increased risk of vitamin D deficiency when exposure to sun is limited (Holick, 2005). Recently the recommendations on protecting the skin from sunshine to reduce the risk of skin cancer later in life has been debated as it may increase the risk of vitamin D deficiency (Stechschulte et al, 2011). Obesity in children might be another risk factor for vitamin D deficiency, since an increased proportion of available vitamin D may be stored in adipose tissue thus lowering the S-25(OH)D (Prentice, 2008).

Despite studies indicating that the vitamin D intake among Swedish children and adolescents are significantly below recommendations, little is known of their vitamin D status (Garemo et al, 2007, Enghardt et al, 2006, Öhlund et al, 2010). Furthermore there is a paucity of studies investigating vitamin D intake and status in food-allergic adolescents who may be at increased risk of vitamin D insufficiency due to strict avoidance of vitamin D containing foods.

Recently the investigators of Dvisum assessed Vitamin D status in pre-school children (n=90; mean age 54+/-7.1 mo), all living in northern Sweden (latitude 63°) and half of them with fair skin, half with darker complexion. The study group was examined first in August-September (late summer) and then the following January-February (winter). Skin type, vitamin D intake, anthropometrics, S-25(OH) D and parathyroid hormone (S-PTH) were assessed. The investigators found inadequate vitamin D status in these children living in northern Sweden, especially in dark-skinned children and during the winter despite vitamin D intakes meeting the recommendations, prompting strategies to improve intake of vitamin D in this population. Overall, 25% and 40% of the light and dark skinned had S-25(OH) D <50 nmol/L.

The aim is to examine which amount of vitamin D is needed to maintain or increase S-25(OH)D to ≥50 nmol/L among 97.5% of the participants regardless of skin color or geographic location (northern or southern Sweden). Furthermore the investigators will examine if vitamin D status affects health markers such as bone density, blood pressure, serum lipids, fatty acids and inflammatory and immunological markers and mental wellbeing.

In order to identify whether there are differences depending on the latitude within Sweden, children will be recruited both from northern Sweden (Umeå) and from southern Sweden (Malmo). As it is unclear what levels of the serological marker 25 (OH) D that affect the health of children, different markers of health will be examined before and after the intervention. Children aged 5-8 years, 50% fair-skin 50 % darker skin, in northern Sweden (Umeå) and southern Sweden (Malmö) will be included in a longitudinal, randomized trial. The children are first examined in November-December and randomized to a vitamin D supplement of either 10 or 25 g per day, to be used for three months. At the follow up in February-March all examinations will be repeated.

The investigators will use a 2 × 2 × 2 factorial design to investigate the effects of two different doses of vitamin D (10 µg and 25 µg) in children with dark and light skin color, living in northern (Umeå) and southern (Malmö), Sweden. In order to achieve a moderate difference between groups (effect size 0.25) requires 20 children per group (power>87%, alpha = 0.05). With this group size, we can see a group difference in the S-25 (OH) D of 3.75 nmol/L, S-PTH of 0.35 mmol/L and bone mineral density in the lumbar region of 0.075 g/cm2. In Skåne, but not Umeå also a placebo group will participate. With an estimated dropout of 10%, a total of 220 children will be included.

The study include sampling for analysis of S-25 (OH) D, calcium, phosphate, alkaline phosphatase (ALP), magnesium, PTH and osteocalcin, serum lipids (total cholesterol, HDL cholesterol, LDL cholesterol. ApoA1 and ApoB lipoprotein) and fatty acids as well as inflammatory and immunological markers (CRP, interleukin (IL) -1 and 2, IL-4, IL-6, I-10, Il-17, CD40 ligand, TNF and IFNγ, fibrinogen and antisecretory factor). Before sampling, the children receive a topical anesthetic (EMLA).

Measurements of blood pressure and anthropometric measurements of length, weight, waist circumference and bone densitometry (DEXA) and body composition (fat mass% and fat free mass) using a Air Displacement Plethysmography ( BOD POD) Questions about diet, vitamin supplements, foreign travel, how much time the children spend time outdoors and the use of sunscreen as well as questions about the child's health and family situation will be answered by the parents through a questionnaire. To investigate the possible association between vitamin D status and mental well-being, the investigators will use the Child Behaviour Checklist (CBCL).

This study is national with a multicultural perspective, it is expected to provide knowledge about the needs of vitamin D to prevent vitamin D deficiency. The study is also expected to provide a better understanding of association between vitamin D status and various markers of health among children.

By preventing vitamin D deficiency, poor bone development, susceptibility to infections, and perhaps prone to autoimmune diseases and cardiovascular risk factors could be reduced, and hopefully the mental well-being improved, which reduces costs to both society and the individual, and reduces unnecessary suffering of individuals.

研究类型

介入性

注册 (实际的)

220

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Skåne
      • Malmö、Skåne、瑞典、20502
        • Department of Pediatrics, University hospital Malmö
    • Västerbotten
      • Umeå、Västerbotten、瑞典、90187
        • Pediatrics, Department of Clinical Sciences, Umeå University

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

5年 至 7年 (孩子)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • 5-7 years of age
  • Healthy

Exclusion Criteria:

  • Chronic illness, including coeliac disease or other chronic gastrointestinal disorders
  • Drugs that can affect bone health or vitamin D uptake
  • Cow's milk allergy

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:阶乘赋值
  • 屏蔽:四人间

武器和干预

参与者组/臂
干预/治疗
实验性的:Umeå, vitamin D 25 microg/d, light skin
Participants with light skin will be randomized to a milk drink providing 25 microg vitamin D3 per day.
The vitamin D supplement will be provided as a milk drink taken daily.
有源比较器:Umeå, vitamin D 10 microg/d, dark skin
Participants with dark skin will be randomized to a milk drink providing 10 microg vitamin D3 per dag.
The vitamin D supplement will be provided as a milk drink taken daily.
有源比较器:Umeå, vitamin D 10 microg/d, light skin
Participants with light skin will be randomized to a milk drink providing 10 microg vitamin D3 per dag.
The vitamin D supplement will be provided as a milk drink taken daily.
实验性的:Malmö, vitamin D 25 microg/d, dark skin
Participants with dark skin will be randomized to a milk drink providing 25 microg vitamin D3 per day.
The vitamin D supplement will be provided as a milk drink taken daily.
实验性的:Malmö, vitamin D 25 microg/d, light skin
Participants with light skin will be randomized to a milk drink providing 10 microg vitamin D3 per day.
The vitamin D supplement will be provided as a milk drink taken daily.
有源比较器:Malmö, vitamin D 10 microg/d, dark skin
Participants with dark skin will be randomized to a milk drink providing 10 microg vitamin D3 per day.
The vitamin D supplement will be provided as a milk drink taken daily.
有源比较器:Malmö, vitamin D 10 microg/d, light skin
Participants with light skin will be randomized to a milk drink providing 10 microg vitamin D3 per day.
The vitamin D supplement will be provided as a milk drink taken daily.
安慰剂比较:Malmö, placebo, dark skin,
Participants with dark skin will be randomized to a milk drink without added vitamin D (placebo).
Milk drink with no extra vitamin D (placebo)
其他名称:
  • 安慰剂
安慰剂比较:Malmö, placebo, light skin
Participants with light skin will be randomized to a milk drink without added vitamin D (placebo).
Milk drink with no extra vitamin D (placebo)
其他名称:
  • 安慰剂
实验性的:Umeå, vitamin D 25 microg/d, dark skin
Participants with dark skin will be randomized to a milk drink providing 25 microg vitamin D3 per day.
The vitamin D supplement will be provided as a milk drink taken daily.

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Serum 25OH-vitamin D levels
大体时间:90 days after start of treatment
90 days after start of treatment

次要结果测量

结果测量
措施说明
大体时间
Bone mineralisation
大体时间:120 days after start of treatment
Bone mineralisation will be measured with DXA-scan, serum PTH and serum osteocalcin
120 days after start of treatment

其他结果措施

结果测量
措施说明
大体时间
Inflammatory and immunological markers
大体时间:90 days after start of treatment
CRP, interleukin (IL) -1 and 2, IL-4, IL-6, I-10, Il-17, CD40 ligand, TNF-alfa, IFNγ, fibrinogen and antisecretory factor
90 days after start of treatment
Behavioral and emotional well-being
大体时间:90 days after start of treatment
Parental assessment using Child Behavioral Checklist
90 days after start of treatment

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

合作者

调查人员

  • 首席研究员:Inger Öhlund, Ph.D.、Umeå University
  • 学习椅:Torbjörn Lind, M.D., Ph.D.、Umeå University
  • 学习椅:Pia Karlsland-Åkesson, M.D., Ph.D.、University hospital, Malmö/Lund
  • 学习椅:Sven-Arne Silfverdal, M.D., Ph.D.、Umeå University
  • 学习椅:Olle Hernell, M.D., Ph.D.、Umeå University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2012年11月1日

初级完成 (实际的)

2013年4月1日

研究完成 (实际的)

2013年7月1日

研究注册日期

首次提交

2012年11月26日

首先提交符合 QC 标准的

2012年11月30日

首次发布 (估计)

2012年12月4日

研究记录更新

最后更新发布 (估计)

2016年11月1日

上次提交的符合 QC 标准的更新

2016年10月31日

最后验证

2016年10月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅